Moldable Bone Filler Using Porous Granule Scaffold
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bone graft materials, such as autografts and allografts, face limitations including limited availability, patient pain, disease transmission risks, and inefficiencies in promoting bone regeneration, necessitating a synthetic alternative that is non-toxic, immunogenic, and capable of bonding with host bone while supporting new bone growth.
Innovation Solution
A moldable bone filler comprising a porous granule scaffold with a cellular component and organic biopolymer, potentially including growth factors and cytokines, designed to mimic natural bone porosity and structure, allowing for precise defect filling and enhanced integration with autologous cells to promote bone regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If autograft bone is used, then bone regeneration is promoted, but patient pain and limited availability occur
Solution Approach 1:
The patent creates a synthetic bone graft material that copies the structural and functional properties of natural bone without requiring actual bone harvesting from the patient. The porous granule scaffold replicates bone's microarchitecture to provide similar osteoconductive and osteoinductive properties while eliminating donor site morbidity and pain associated with autograft harvesting
Solution Approach 2:
The invention uses composite materials combining porous granules (hydroxyapatite, beta-tricalcium phosphate) with organic biopolymers (collagen, gelatin, fibrin) to create a synthetic bone graft that mimics natural bone's composite structure. This composite approach provides both structural integrity and biological activity without requiring patient bone tissue
2Reliability
If allograft bone is used, then bone regeneration is promoted, but disease transmission risk occurs
Solution Approach 1:
The patent employs a synthetic, disposable bone graft material that does not require donor tissue, thereby eliminating the risk of disease transmission associated with allografts. The porous granule scaffold is designed to be single-use and biodegradable, providing bone regeneration without the complications of donor tissue evaluation and disease screening
3Strength
If rigid implant is used, then structural strength is provided, but adaptability to defect contours is reduced
Solution Approach 1:
The patent transforms the rigid implant paradigm by creating a moldable bone graft material that can dynamically adapt to the contours of the defect site. The porous granule scaffold combined with organic biopolymers allows the implant to be shaped to match the patient's anatomy, providing both structural strength and adaptability without requiring rigid pre-formed shapes
4Productivity
If bone marrow concentrate is delivered, then healing is accelerated, but delivery complexity increases
Solution Approach 1:
The patent merges the delivery of bone marrow concentrate with the bone graft scaffold itself. The porous granule scaffold serves as both the structural support and the delivery vehicle for concentrated bone marrow and growth factors, eliminating the need for separate delivery systems and simplifying the overall procedure while accelerating healing
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The filler effectively supports bone regeneration by providing a high surface area for cell attachment, promoting osteogenic differentiation, and accelerating healing by delivering concentrated progenitor cells directly to the defect site, reducing surgical time and trauma, and enhancing bone remodeling.
Implementation Method 1
A moldable bone filler comprising a porous granule scaffold with a cellular component and organic biopolymer, potentially including growth factors and cytokines, designed to mimic natural bone porosity and structure
Implementation Method 2
accelerating healing by delivering concentrated progenitor cells directly to the defect site, reducing surgical time and trauma, and enhancing bone remodeling
Implementation Method 3
capable of bonding with the host bone, capable of supporting in-growth of new bone into the graft
Data Source
AI summary
The invention is directed to a bone void filler comprising a scaffold or matrix. The scaffold or matrix may include a porous inorganic matrix component. The bone void filler may include a cellular component containing cells, some of which are capable of making extracellular matrix resembling native bone tissue. The bone void filler may include an organic matrix, such as, an organic biopolymer that aids in cell retention and renders the scaffold or matrix moldable. The bone void filler may include growth factors and/or cytokines. The bone void filler may include a clotting agent.


